Create a narrative

Emergent BioSolutions Community

NYSE:EBS Community

1 Narratives written by author
1 Comments on narratives written by author
18 Fair Values set on narratives written by author

Create a narrative

Emergent BioSolutions

AN

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

Transformational Initiatives Will Optimize Medical Countermeasures And Operations

Key Takeaways Strategic refocus on medical countermeasures and NARCAN Nasal Spray aims to maintain market leadership and drive revenue growth. Transformational plan, manufacturing optimization, and partnerships target improved profitability, efficiency, and diversified revenue streams.

US$13.50

FV

59.6% undervalued

7.49%

Revenue growth p.a.

0

0

1

2 days ago